BMRN vs CRACR
Biomarin Pharmaceutical Inc (BMRN) versus Crown Reserve Acquisition Corp. I Rights (CRACR) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Crown Reserve Acquisition Corp. I Rights (CRACR) common stock listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
CRACR does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CRACR currently screens at market cap $0.
Not investment advice. Open the BMRN and CRACR stock pages for the full models.
Not investment advice.